Aktiesnakken — September 2013
-
6+% i after hours. De daglige udsving i SPPI er nærmest umulige at forudsige. Men den har pt. støtte i 7 og modstand ca. 8,3.
-
Men de lancerede Marqibo igår. 1 måned før det var forventet og har allerede shipped the first orders, så der kommer ordre fra Marqibo med i Q3. Nu har SPPI 4 FDA approved drugs i pipelienn
-
Spændende artikel. Dog meget gætteri: http://medwatch.dk/secure/Medicinal___Biotek/article5905006.ece
-
"Forsøger Spectrum at dræne TopoTarget"
-
mornings
-
Stadig en god langsigtet investering http://www.proinvestor.com/investornyt/82807/eksplosion-i-antallet-af-diabetikere-i-kina
-
JKY. Jeg glæder mig til at se hvilken markedsandel Lyxumia kan tage i Asien, spåeciet Japan
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind